Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa.
Calabrese L, Malvaso D, Coscarella G, Antonelli F, D'Amore A, Gori N, Rubegni P, Peris K, Chiricozzi A. Calabrese L, et al. Among authors: malvaso d. Biomolecules. 2024 Feb 1;14(2):175. doi: 10.3390/biom14020175. Biomolecules. 2024. PMID: 38397412 Free PMC article. Review.
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study.
Antonelli F, Ippoliti E, Rosi E, Moltrasio C, Malvaso D, Botti E, Abeni D, Dini V, Cannizzaro MV, Bruni M, Di Nardo L, Fargnoli MC, Romanelli M, Fania L, Bianchi L, Marzano AV, Prignano F, Peris K, Chiricozzi A. Antonelli F, et al. Among authors: malvaso d. J Clin Med. 2023 Dec 18;12(24):7754. doi: 10.3390/jcm12247754. J Clin Med. 2023. PMID: 38137823 Free PMC article.
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab.
Quattrini L, Chiricozzi A, Gori N, DI Nardo L, D'Urso DF, Malvaso D, Cornacchia L, Catapano S, Peris K. Quattrini L, et al. Among authors: malvaso d. Ital J Dermatol Venerol. 2023 Aug;158(4):365-367. doi: 10.23736/S2784-8671.23.07475-3. Epub 2023 Jul 11. Ital J Dermatol Venerol. 2023. PMID: 37432395 No abstract available.
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study.
Burlando M, Fabbrocini G, Marasca C, Dapavo P, Chiricozzi A, Malvaso D, Dini V, Campanati A, Offidani A, Dattola A, Caro RDC, Bianchi L, Venturini M, Gisondi P, Guarneri C, Malara G, Trifirò C, Malagoli P, Fargnoli MC, Piaserico S, Carmisciano L, Castelli R, Parodi A. Burlando M, et al. Among authors: malvaso d. Biomedicines. 2022 Oct 9;10(10):2522. doi: 10.3390/biomedicines10102522. Biomedicines. 2022. PMID: 36289787 Free PMC article.
18 results